OXOPHOSPHETANE-B8,DIASTEREOMERE-#1
Compound with spectra: 2 NMR
| SpectraBase Compound ID | JCgfoP3gthg |
|---|---|
| InChI | InChI=1S/C27H29OP/c1-21-27(20-22-17-18-23(27)19-22)28-29(21,24-11-5-2-6-12-24,25-13-7-3-8-14-25)26-15-9-4-10-16-26/h2-16,21-23H,17-20H2,1H3/t21?,22-,23+,27-/m0/s1 |
| InChIKey | VXLSRFCSQYCMFB-CARWCEBDSA-N |
| Mol Weight | 400.5 g/mol |
| Molecular Formula | C27H29OP |
| Exact Mass | 400.195603 g/mol |
| Enantiomer InChIKey | VXLSRFCSQYCMFB-FTLVJZLWSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | THF |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | THF |
- OXOPHOSPHETANE-B8,DIASTEREOMERE-#2
2-(1,1,1,3,3,3-hexafluoropropan-2-yloxy)-3-methyl-2,2-di(phenyl)-4,4-bis(trifluoromethyl)-1-oxa-2$l^{5}-phosphacyclobutane
4-BROMO-5-BUTYL-5-METHYL-2,2-DIPHENYL-3-[(TETRAHYDRO-2H-PYRAN-2-YL-OXY)-METHYL]-2,5-DIHYDRO-1,2-OXAPHOSPHOL-2-IUM-BROMIDE
Eriodictyol, tetra-TMS
Dimethyl 2-(1,3-dimethylbarbituric acid-5-yl-5-ylid)-3-triphenylphosphoniobutane-1,4-dioate
3-({[4-ethyl-3-(methoxycarbonyl)-5-methyl-2-thienyl]amino}carbonyl)bicyclo[2.2.2]oct-5-ene-2-carboxylic acid
EXIGUAFLAVANONE-K;8-GAMMA,GAMMA-DIMETHYLALLYL-5,7,4'-TRIHYDROXY-3'-METHOXYFLAVANONE
Cumyl-CP-MICA-TMS
2,3-Dimethyl-5,18-dioxapentacyclo[10.6.0.0(4,11)06,10).013,17)]octadeca-1,2,4,7,15-pentaene
butanamide, 2-[[(4E)-1-(3-chloro-4-methoxyphenyl)-4,5-dihydro-4-[(4-methylphenyl)methylene]-5-oxo-1H-imidazol-2-yl]thio]-N-cyclohexyl-
PRODEOXY-VIOACEIN
| Title | Journal or Book | Year |
|---|---|---|
| Low-temperature characterization of the intermediates in the Wittig reaction | Journal of the American Chemical Society | 1981 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.